Effects of Intravitreal Faricimab 6.0 mg Injection on Functional and Anatomic Outcomes in Patients with Neovascular Age-related Macular Degeneration

被引：0
|
作者：
Pandit, Saagar [1 ]
Wakabayashi, Taku [1 ]
Mansour, Hana [1 ]
Pashaee, Bahram [2 ]
Chiang, Allen [1 ]
Hsu, Jason [1 ]
机构：
[1] Wills Eye Hosp & Res Inst, Retina, Philadelphia, PA USA
[2] Thomas Jefferson Univ, Populat Hlth, Philadelphia, PA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2235
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [1] Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration
    Aljundi, Wissam
    Munteanu, Cristian
    Seitz, Berthold
    Abdin, Alaa Din
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (09) : 2867 - 2874
  • [2] Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
    Rush, Ryan B.
    Rush, Sloan W.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 4041 - 4046
  • [3] Visual and Anatomical Outcomes After Initial Intravitreal Faricimab Injection for Neovascular Age-Related Macular Degeneration in Patients with Prior Treatment History
    Inoda, Satoru
    Takahashi, Hidenori
    Takahashi, Ryota
    Hashimoto, Yuto
    Yoshida, Hana
    Takahashi, Hironori
    Takayama, Takuya
    Kawashima, Hidetoshi
    Yanagi, Yasuo
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (05) : 2703 - 2712
  • [4] Visual and Anatomical Outcomes After Initial Intravitreal Faricimab Injection for Neovascular Age-Related Macular Degeneration in Patients with Prior Treatment History
    Satoru Inoda
    Hidenori Takahashi
    Ryota Takahashi
    Yuto Hashimoto
    Hana Yoshida
    Hironori Takahashi
    Takuya Takayama
    Hidetoshi Kawashima
    Yasuo Yanagi
    Ophthalmology and Therapy, 2023, 12 : 2703 - 2712
  • [5] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    DRUGS & AGING, 2012, 29 (10) : 839 - 846
  • [6] Intravitreal conbercept injection for neovascular age-related macular degeneration
    Wu, Bing-Hui
    Wang, Bing
    Wu, Hui-Qin
    Chang, Qin
    Lu, Hui-Qin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2019, 12 (02) : 252 - 257
  • [7] Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
    Pandit, Saagar A.
    Momenaei, Bita
    Wakabayashi, Taku
    Mansour, Hana A.
    Vemula, Sudheshna
    Durrani, Asad F.
    Pashaee, Bahram
    Kazan, Adina S.
    Ho, Allen C.
    Klufas, Michael
    Regillo, Carl
    Yonekawa, Yoshihiro
    Hsu, Jason
    Kuriyan, Ajay
    Chiang, Allen
    OPHTHALMOLOGY RETINA, 2024, 8 (04): : 360 - 366
  • [8] Clinical Outcomes of Intravitreal Brolucizumab Injection for Refractory Neovascular Age-related Macular Degeneration
    Lee, Jun Young
    Park, No Hae
    Kwon, Han Jo
    Park, Sung Who
    Byon, Ik Soo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (09): : 596 - 604
  • [9] Short-term outcomes of intravitreal faricimab for treatment-naive neovascular age-related macular degeneration
    Matsumoto, Hidetaka
    Hoshino, Junki
    Nakamura, Kosuke
    Nagashima, Tetsuhiro
    Akiyama, Hideo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (10) : 2945 - 2952
  • [10] Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Ohr, Matthew
    Kaiser, Peter K.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (04) : 585 - 591
12345